The False Claims Act is not limited only to domestic instances of fraud against the government. To the contrary, companies headquartered in other countries are routinely targeted for fraud investigations, including a recent False Claims Act case against a Netherlands-based drug company now owned by the more familiar corporation Merck. […]
Biotronik, Inc., a medical device manufacturer, has agreed to pay $4.9 million to settle claims it unlawfully engaged in kickback schemes and prohibited financial arrangements in violation of the False Claims Act and its terms forbidding kickback schemes pertaining to Medicare and Medicaid patients. The company settled with the Department […]
New Jersey-based Biomet, Inc. has agreed to pay $6.07 million to settle False Claims Act allegations involving kickbacks pertaining to its bone growth stimulator products. Under the False Claims Act, any medical device manufacturer, drug company, hospital, or medical professional may face possible liability if Medicare or Medicaid patients are […]
Houston-based One Step Diagnostic, which operates several medical imaging diagnostic centers around Houston, Texas, has agreed to pay $2.6 million to the federal government in order to settle claims it engaged in unlawful kickbacks and inappropriate financial relationships in violation of the False Claims Act and federal Stark Law. The […]
We have covered the False Claims Act evidentiary standard from a number of different angles. At the pleadings phase of these cases, there is a near 50/50 split between the circuit courts as to the specificity of alleged fraud necessary to overcome a motion to dismiss under Federal Rule of […]